TABLE 2.

HPV-16 DNA, HPV-16 E6 and E7 CTL, and HPV-16 VLP IgG antibody results for four subjects with two periods of HPV-16 DNA detection

Subject	Duration of HPV-16 DNA detection (mo)	Presence or absence of CTL or Aba
		After clearance of 1st HPV-16 infection		During 2nd HPV-16 DNA detection period		After clearance of 2nd HPV-16 infection
		CTL (E6/E7)	VLP Ab	CTL (E6/E7)	VLP Ab	CTL (E6/E7)	VLP Ab
5b	11	+	+	−	+	−	+
	<4
6	Unknown	−	−	+	+	+	+
	<4
7b	28	−	+	+	+	+	+
	<4
8	<4	NAc	NA	NA	NA	−	+
	<4

^aAb, antibody.

^bSubject was HPV-16 VLP antibody positive during the first period of HPV-16 DNA detection.

^cNA, analysis not initiated during the corresponding period of detection.